References
- D'Amico, G. The commonest glomerulonephritis in the world: IgA nephropathy. Q. J. Med. 1987, 64 (245), 709–727. [PUBMED], [INFOTRIEVE]
- Julian, B A.; Waldo, F B.; Rifai, A.; Mestecky, J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am. J. Med. 1988, 84 (1), 129–132. [PUBMED], [INFOTRIEVE], [CROSSREF]
- D'Amico, G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am. J. Kidney Dis. 2000, 36 (2), 227–237. [PUBMED], [INFOTRIEVE]
- Donadio, J V.; Grande, J P. IgA nephropathy. N. Engl. J. Med. 2002, 347 (10), 738–748. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Strippoli, G F.; Manno, C.; Schena, F P. An-evidence-based-survey of therapeutic options for IgA nephropathy: assessment and criticism. Am. J. Kidney Dis. 2003, 41 (6), 1129–1139. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pozzi, C.; Andrulli, S.; Del Vecchio, L.; Melis, P.; Fogazzi, G B.; Altieri, P.; Ponticelli, C.; Locatelli, F. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J. Am. Soc. Nephrol. 2004, 15 (1), 157–163. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Praga, M.; Gutierrez, E.; Gonzalez, E.; Morales, E.; Hernandez, E. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J. Am. Soc. Nephrol. 2003, 14 (6), 1578–1583. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yasuhiko, Y.; Sakai, H. Special study group (IgA nephropathy) on progressive glomerular disease. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin. Exp. Nephrol. 2003, 7 (2), 93–97. [CROSSREF], [CSA]
- D'Amico, G.; Minetti, L.; Ponticelli, C.; Fellin, G.; Ferrario, F.; Belgioioso, G.; Imbasciati, E.; Ragni, A.; Bertoli, S.; Fogazzi, G. Prognostic indications in idiopathic IgA mesangial nephropathy. Q. J. Med. 1986, 59 (228), 363–378. [PUBMED], [INFOTRIEVE]
- Johnston, P A.; Brown, J S.; Braumholtz, D A.; Davison, A M. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC glomerulonephritis registry. Q. J. Med. 1992, 84 (304), 619–627. [PUBMED], [INFOTRIEVE]
- Radford, M G., Jr.; Donadio, Jr.; Bergstralh, E J.; Grande, J P. Predicting renal outcome in IgA nephropathy. J. Am. Soc. Nephrol. 1997, 8 (2), 199–207. [PUBMED], [INFOTRIEVE], [CSA]
- Frimat, L.; Briancon, S.; Hestin, D.; Aymard, B.; Renoult, E.; Huu, T C.; Kessler, M. IgA nephropathy: prognostic classification of end-stage renal failure. Nephrol. Dial. Transplant. 1997, 12 (12), 2569–2575. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Daniel, L.; Saingra, Y.; Giorgi, R.; Bouvier, C.; Pellissier, J F.; Berland, Y. Tubular lesions determine prognosis of IgA nephropathy. Am. J. Kidney Dis. 2000, 35 (1), 13–20. [PUBMED], [INFOTRIEVE]
- Geddes, C C.; Rauta, V.; Gronhagen-Riska, C.; Bartosik, L P.; Jardine, A G.; Ibels, L S.; Pei, Y.; Cattran, D C. A tricontinental view of IgA nephropathy. Nephrol. Dial. Transplant. 2003, 18 (8), 1541–1548. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Alamartine, E.; Sabatier, J C.; Guerin, C.; Berliet, J M.; Berthoux, F. Prognostic factors in mesangialIgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am. J. Kidney Dis. 1991, 18 (1), 12–19. [PUBMED], [INFOTRIEVE]
- Rekola, S.; Bergstrand, A.; Bucht, H. Development of hypertension in IgA nephropathy as a marker of a poor prognosis. Am. J. Nephrol. 1990, 10 (4), 290–295. [PUBMED], [INFOTRIEVE]
- Payton, C D.; McLay, A.; Jones, J M. Progressive IgA nephropathy: the role of hypertension. Nephrol. Dial. Transplant. 1988, 3 (2), 138–142. [PUBMED], [INFOTRIEVE]
- Bartosik, L P.; Lajoie, G.; Sugar, L.; Cattran, D C. Predicting progression in IgA nephropathy. Am. J. Kidney Dis. 2001, 38 (4), 728–735. [PUBMED], [INFOTRIEVE]
- Donadio, J V.; Bergstralh, E J.; Grande, J P.; Rademcher, D M. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol. Dial. Transplant. 2002, 17 (7), 1197–1203. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kobayashi, Y.; Hiki, Y.; Kokubo, T.; Horii, A.; Tateno, S. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron 1996, 72 (2), 237–242. [PUBMED], [INFOTRIEVE], [CSA]
- Shoji, T.; Nakanishi, I.; Suzuki, A.; Hayashi, T.; Togawa, M.; Okada, N.; Imai, E.; Hori, M.; Tsubakihara, Y. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am. J. Kidney Dis. 2000, 35 (2), 194–201. [PUBMED], [INFOTRIEVE]
- Pozzi, C.; Bolasco, P G.; Fogazzi, G B.; Andrulli, S.; Altieri, P.; Ponticelli, C.; Locatelli, F. Corticosteroids in IgA nephropathy: a randomized controlled trial. Lancet 1999, 353 (9156), 883–887. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rasche, F M.; Schwarz, A.; Keller, F. Tonsillectomy does not prevent a progressive course in IgA nephropathy. Clin. Nephrol. 1999, 51 (3), 147–152. [CSA]
- Hotta, O.; Miyazaki, M.; Furuta, T.; Tomioka, S.; Chiba, S.; Horigome, I.; Abe, K.; Taguma, Y. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am. J. Kidney Dis. 2001, 38 (4), 736–743. [PUBMED], [INFOTRIEVE]
- Xie, Y.; Nishi, S.; Ueno, M.; Imai, N.; Sakatsume, M.; Narita, I.; Suzuki, Y.; Akazawa, K.; Shimada, H.; Arakawa, M.; Gejyo, F. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003, 63 (5), 1861–1867. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maschio, G.; Cagnoli, L.; Claroni, F.; Fusaroli, M.; Rugiu, C.; Sanna, G.; Sasdelli, M.; Zuccala, A.; Zucchelli, P. ACE inhibitor reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol. Dial. Transplant. 1994, 9 (3), 265–269. [PUBMED], [INFOTRIEVE], [CSA]
- Bannister, K M.; Weaver, A.; Clarkson, A R.; Woodroffe, A J. Effect of angiotensin-converting enzyme and calcium channel inhibition on progression of IgA nephropathy. Contrib. Nephrol. 1995, 111, 184–192. [PUBMED], [INFOTRIEVE], [CSA]